About ChromaDex
ChromaDex is a company based in Irvine (United States) founded in 1999.. ChromaDex has raised $3.39 million across 23 funding rounds from investors including dsm-firmenich, Hercules Capital and Western Alliance Bank. The company has 228 employees as of December 31, 2022. ChromaDex offers products and services including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards. ChromaDex operates in a competitive market with competitors including Kapiva, Labomar, Setu, BBetter and LifeVantage, among others.
- Headquarter Irvine, United States
- Employees 228 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Niagen Bioscience
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.39 M (USD)
in 23 rounds
-
Latest Funding Round
$16.39 M (USD), Post-IPO
Feb 22, 2021
-
Investors
dsm-firmenich
& 4 more
-
Employee Count
228
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ChromaDex
ChromaDex offers a comprehensive portfolio of products and services, including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
NAD-boosting supplement for enhancing cellular health and longevity.
Advanced therapy for fast-acting NAD+ enhancement in health enthusiasts.
Proprietary components for dietary supplements and pharmaceutical use.
Standards for scientific studies in NAD+ and related fields.
Unlock access to complete
Unlock access to complete
Funding Insights of ChromaDex
ChromaDex has successfully raised a total of $3.39M across 23 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.39 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Post-IPO — $16.4M
-
First Round
First Round
(01 Feb 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Post-IPO - ChromaDex | Valuation |
investors |
|
| May, 2020 | Amount | Post-IPO - ChromaDex | Valuation |
investors |
|
| Aug, 2019 | Amount | Post-IPO - ChromaDex | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ChromaDex
ChromaDex has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include dsm-firmenich, Hercules Capital and Western Alliance Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Founded Year | Domain | Location | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Commercial banking services, including loans and treasury management, are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ChromaDex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ChromaDex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chromadex Comparisons
Competitors of ChromaDex
ChromaDex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, Labomar, Setu, BBetter and LifeVantage, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| domain | founded_year | HQ Location |
Dietary supplements, diet foods, health products, and medical devices
|
|
| domain | founded_year | HQ Location |
Dietary supplements with herbal extracts and vitamins are provided.
|
|
| domain | founded_year | HQ Location |
Nutritional supplements are provided to enhance health and wellness.
|
|
| domain | founded_year | HQ Location |
Nutritional products for various health ailments are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chromadex
Frequently Asked Questions about ChromaDex
When was ChromaDex founded?
ChromaDex was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Where is ChromaDex located?
ChromaDex is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Is ChromaDex a funded company?
ChromaDex is a funded company, having raised a total of $3.39M across 23 funding rounds to date. The company's 1st funding round was a Post-IPO of $7M, raised on Feb 01, 2007.
How many employees does ChromaDex have?
As of Dec 31, 2022, the latest employee count at ChromaDex is 228.
What does ChromaDex do?
ChromaDex was founded in 1999 in Irvine, United States, within the health and wellness sector. Nutritional ingredients are developed by the company, with operations centered on research into nicotinamide adenine dinucleotide (NAD), levels of which decline with age. Niagen is provided as the sole active ingredient in the consumer product Tru Niagen, supporting broader efforts in nutritional innovation.
Who are the top competitors of ChromaDex?
ChromaDex's top competitors include Kapiva, Setu and LifeVantage.
What products or services does ChromaDex offer?
ChromaDex offers Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards.
Who are ChromaDex's investors?
ChromaDex has 5 investors. Key investors include dsm-firmenich, Hercules Capital, Western Alliance Bank, Horizons Ventures, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.